National survey for chemotherapy-induced nausea and vomiting

National survey for chemotherapy-induced nausea and vomiting - CINV study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005971

Enrollment

2000

Registered

2011-07-13

Start date

2011-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant neoplasm

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who are to receive moderate to high-risk emetogenic chemotherapy for the first time

Exclusion criteria

Exclusion criteria: patients who had experienced nausea and vomiting within 24 hours prior to the start of chemotherapy

Design outcomes

Primary

Measure	Time frame
1)incidence of CINV(acute and delayed) 2)difference between the incidence of CINV and perception against CINV by the doctors, nurses and pharmacists	—

Secondary

Measure	Time frame
1) sabset analysis of CINV 2) oral intake 3) incidence of rescue treatment for breakthrough nausea and vomiting	—

Countries

Japan

Contacts

Public ContactKazuo Tamura

Fukuoka University CINV secretariat

ktamura@fukuoka-u.ac.jp092-801-2845

Outcome results